GlassScriptPhysician profile
Rami N Payman
NPI 1134239445
$3,747.50
in general payments reported to CMS, 2019-2025
24 companies · $741 in 2025
The $741 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $244 · 2021: $126 · 2022: $530 · 2023: $753 · 2024: $940 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,400 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.69 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $785.22 | 2019-2025 | |
| Glaxosmithkline, LLC. | $715.33 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Somnomed INC. | $463.08 | 2024 | |
| Acclarent, INC | $366.39 | 2019-2023 | Acclarent Aera, Trudi Nav Cable, Acclarent Navwire |
| Regeneron Healthcare Solutions, INC. | $313.11 | 2019-2025 | Dupixent |
| Optinose US, INC. | $246.16 | 2019-2025 | |
| Medtronic, INC. | $137.27 | 2024-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Kaleo, INC. | $125.99 | 2022-2024 | Auvi-Q |
| Inspire Medical Systems, INC. | $110.88 | 2023-2025 | Inspire |
| Amgen INC. | $66.13 | 2025 | Tezspire |
| Stryker Corporation | $57.77 | 2019 | |
| Intersect Ent, INC. | $50.11 | 2019 | |
| Aerin Medical INC. | $49.89 | 2025 | |
| Novartis Pharmaceuticals Corporation | $43.52 | 2019 | |
| Medtronic USA, INC. | $36.04 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $34.08 | 2023-2024 | Fasenra, Tezspire |
| Ars Pharmaceuticals Operations, INC. | $24.78 | 2025 | Neffy |
| Kedrion Biopharma, INC. | $23.83 | 2024 | Koate, Kedrab, Gammaked |
| Smith+Nephew, INC. | $17.72 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.32 | 2024 | Voquezna |
| Cochlear Americas | $17.19 | 2024 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Teva Pharmaceuticals USA, INC. | $17.08 | 2020 | |
| Merck Sharp & Dohme LLC | $15.97 | 2023 | |
| Arbor Pharmaceuticals, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Payman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.